The short answer
Medical cannabis does not treat cancer. No cannabis product is approved by the FDA to shrink tumors, slow tumor growth, or replace chemotherapy, radiation, surgery, or immunotherapy. What cannabis and cannabinoid medicines can do is relieve some of the symptoms of cancer and the side effects of its treatment, mainly nausea and vomiting, appetite loss, pain, anxiety, and insomnia. Two synthetic THC drugs, dronabinol and nabilone, are FDA-approved for chemotherapy-induced nausea and vomiting. Botanical cannabis, the flower and edibles sold in state programs, is not FDA-approved for any indication.
medical cannabis for cancer appetite
Where the evidence is strongest
The best-supported use is chemotherapy-induced nausea and vomiting that has not responded to standard drugs. Oral cannabinoids have performed about as well as older antiemetics in trials, though not better than modern combinations of 5-HT3 blockers and NK1 antagonists. Beyond that, the picture gets softer.
Medical Cannabis for Cancer Patients: What Reddit Threads Actually Say
- Appetite and weight: modest benefit in some patients, especially with advanced disease and cachexia.
- Cancer pain: small to moderate reduction when added to opioids, which sometimes allows a lower opioid dose.
- Sleep and anxiety: often reported as helpful, but controlled data are thin and hard to separate from the pain and nausea relief itself.
- Neuropathic pain from chemotherapy: mixed results, with some trials showing little difference from placebo.
Where it falls short
Preclinical work shows cannabinoids can kill cancer cells in a dish or slow tumors in mice. That has not translated into proven human treatment, and it is a long way from a lab result to a cancer therapy. The real danger here is delay. Someone who swaps oncology care for cannabis oil loses time that treatment cannot get back. If you hear a claim that a product cures cancer, treat it as a sales pitch, not a medical finding.
medical cannabis for cancer pain
CBD deserves its own note. A purified CBD drug is FDA-approved for severe childhood seizure disorders, not for cancer. That approval does not extend to cancer care.
How it gets used in practice
Synthetic cannabinoids
Dronabinol and nabilone are prescription capsules with known dosing and no batch-to-batch variation. Many oncologists prefer them for nausea because the dose is predictable.
Oral and sublingual cannabis
Tinctures, capsules, and edibles take 30 to 120 minutes to kick in and last six to eight hours. They are easier on the lungs and better for all-day symptom control, but the slow onset tempts people to redose too early.
Inhaled cannabis
Vaporization or smoking works within minutes and wears off in two to three hours. That speed helps with breakthrough nausea, though smoking adds pulmonary risk, and I would steer anyone with lung involvement away from it.
THC-dominant products tend to be chosen for nausea, appetite, and pain. CBD-dominant products are often picked for anxiety, but the evidence there is weaker than the marketing suggests.
Risks worth knowing
- Drug interactions: cannabinoids are metabolized through CYP3A4 and CYP2C19, the same enzymes used by warfarin, some chemotherapy agents, immunosuppressants, and certain antifungals.
- Additive sedation with opioids, benzodiazepines, and antihistamines, which raises fall risk in older adults.
- Dizziness, confusion, and short-term memory problems, mostly at higher THC doses.
- Psychosis or severe anxiety in people who are predisposed, particularly with high-THC products.
- Edible dosing errors, since effects are delayed and easy to overshoot.
- Driving impairment, which applies even when you feel fine.
Talking to your oncology team
Bring it up rather than hiding it. Clinicians ask about cannabis because it changes how they manage nausea, pain, and sedation, not to judge. Be specific: product type, THC and CBD percentages, how much, how often, and what it changed. Change one thing at a time so you can tell what actually helped. Keep a simple symptom log for a week or two before your next appointment. In states with medical programs, you will need a certification from a qualifying provider, and dispensary products vary widely in potency, so I look for labels that state THC and CBD content and include third-party lab testing.
Legal status in the US
Cannabis remains a Schedule I controlled substance under federal law, while more than half the states run medical programs. Federal agencies have been reviewing rescheduling, so the rules can shift. FDA-approved cannabinoid drugs and state-legal botanical cannabis are two different regulatory worlds, and your access depends on where you live.
The bottom line
Cannabis is a supportive care tool, not a cancer treatment. It may help you eat, sleep, and get through chemo with less nausea. It will not shrink a tumor. Use it alongside oncology care, with your team informed, and be skeptical of anyone promising a cure.